Geode Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.93M | Sell |
|
|||||
|
2025
Q1 | $5.91M | Buy |
|
|||||
|
2024
Q4 | $6.42M | Sell |
|
|||||
|
2024
Q3 | $6.45M | Sell |
|
|||||
|
2024
Q2 | $6.65M | Buy |
|
|||||
|
2024
Q1 | $7.61M | Buy |
|
|||||
|
2023
Q4 | $5.51M | Buy |
|
|||||
|
2023
Q3 | $5.18M | Buy |
|
|||||
|
2023
Q2 | $6.15M | Buy |
|
|||||
|
2023
Q1 | $4.99M | Buy |
|
|||||
|
2022
Q4 | $6.91M | Buy |
|
|||||
|
2022
Q3 | $7.9M | Buy |
|
|||||
|
2022
Q2 | $8.25M | Buy |
|
|||||
|
2022
Q1 | $7.43M | Sell |
|
|||||
|
2021
Q4 | $9.66M | Buy |
|
|||||
|
2021
Q3 | $36.2M | Buy |
|
|||||
|
2021
Q2 | $14.5M | Buy |
|
|||||
|
2021
Q1 | $17M | Buy |
|
|||||
|
2020
Q4 | $11.2M | Buy |
|